retatrutide type 2 diabetes trial The data just dropped — and is rewriting what's possible in obesity medicine. 🧬 TRIUMPH-1 just released Phase 3 results, and the numbers are unlike anything we've seen from a medication Phase 2 Trial of Retatrutide

A separate and equally important counterpoint: a detailed 2026 evidence review published by Barbell Medicine found that GLP-1 medications do not appear to cause muscle loss beyond what matched caloric restriction produces on its own

For example, in clinical trials of Wegovy (semaglutide), eructation was reported in 5.8% of patients versus 0% in the placebo group

In the gastrointestinal tract, GLP-1 receptor activation slows gastric emptying, which contributes to improved postprandial glucose control and increased satiety

We recommend the following minimum protein intake: 60-75 grams per day for most individuals Higher intake if your BMI is over 40 kg/m or if youre very physically active If you dont get enough protein, your body may increase hunger cues to drive intake

Availability and Cost

The Defined Profile Package is fully customized by your provider based on your facial anatomy and aesthetic goals